BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1567 related articles for article (PubMed ID: 8863832)

  • 21. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
    Tso PH; Wong YH
    J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct muscarinic receptors, G proteins and phospholipases in esophageal and lower esophageal sphincter circular muscle.
    Sohn UD; Harnett KM; De Petris G; Behar J; Biancani P
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1205-14. PubMed ID: 8263781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C.
    Liu M; Simon MI
    Nature; 1996 Jul; 382(6586):83-7. PubMed ID: 8657310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipase C isoforms in vascular smooth muscle and their regulation by G-proteins.
    Blayney LM; Gapper PW; Newby AC
    Br J Pharmacol; 1996 Jun; 118(4):1003-11. PubMed ID: 8799575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
    Pobiner BF; Northup JK; Bauer PH; Fraser ED; Garrison JC
    Mol Pharmacol; 1991 Aug; 40(2):156-67. PubMed ID: 1908548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor.
    Murthy KS; Teng BQ; Zhou H; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G974-80. PubMed ID: 10859228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S; Polastron J; Hasbi A; Homburger V; Jauzac P
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
    Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
    Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-beta1 via Galphaq/11 and to PLC-beta3 via Gbetagammai3.
    Murthy KS; Makhlouf GM
    J Biol Chem; 1998 Feb; 273(8):4695-704. PubMed ID: 9468531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
    Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
    Seifert R; Hagelüken A; Höer A; Höer D; Grünbaum L; Offermanns S; Schwaner I; Zingel V; Schunack W; Schultz G
    Mol Pharmacol; 1994 Apr; 45(4):578-86. PubMed ID: 7514261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist-independent, muscle-type-specific signal transduction pathways in cat esophageal and lower esophageal sphincter circular smooth muscle.
    Sohn UD; Han B; Tashjian AH; Behar J; Biancani P
    J Pharmacol Exp Ther; 1995 Apr; 273(1):482-91. PubMed ID: 7536246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
    Murthy KS; Grider JR; Makhlouf GM
    J Pharmacol Exp Ther; 1992 Jan; 260(1):90-7. PubMed ID: 1309882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
    Remmers AE; Clark MJ; Liu XY; Medzihradsky F
    J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection.
    Hu W; Mahavadi S; Huang J; Li F; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G605-10. PubMed ID: 16675745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin receptors in NIH 3T3 cells: coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C.
    Gusovsky F
    Mol Pharmacol; 1991 Nov; 40(5):633-8. PubMed ID: 1658602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.